Your browser doesn't support javascript.
loading
Using imlifidase to elucidate the characteristics and importance of anti-GBM antibodies produced after start of treatment.
Tyrberg, Linnéa; Andersson, Fanny; Uhlin, Fredrik; Hellmark, Thomas; Segelmark, Mårten.
Affiliation
  • Tyrberg L; Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Andersson F; AT-unit, Helsingborg Hospital, Helsingborg, Sweden.
  • Uhlin F; Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Hellmark T; Department of Nephrology and Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.
  • Segelmark M; Department of Health Technologies, Tallinn University of Technology, Tallinn, Estonia.
Nephrol Dial Transplant ; 39(1): 45-54, 2023 Dec 20.
Article in En | MEDLINE | ID: mdl-37385828
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antibodies, Antineutrophil Cytoplasmic / Anti-Glomerular Basement Membrane Disease Limits: Humans Language: En Journal: Nephrol Dial Transplant Journal subject: NEFROLOGIA / TRANSPLANTE Year: 2023 Document type: Article Affiliation country: Suecia Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antibodies, Antineutrophil Cytoplasmic / Anti-Glomerular Basement Membrane Disease Limits: Humans Language: En Journal: Nephrol Dial Transplant Journal subject: NEFROLOGIA / TRANSPLANTE Year: 2023 Document type: Article Affiliation country: Suecia Country of publication: Reino Unido